MICHAEL MAREK: Open Payments
NPI 1285004853 · WEXFORD, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$317 in 18 payments from 5 companies in 2025. Trend: 2023 $0 · 2024 $53 · 2025 $317
Food & beverage: $317
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $184 |
| Otsuka America Pharmaceutical, Inc. | 3 | $62 |
| Supernus Pharmaceuticals, Inc. | 1 | $38 |
| Lundbeck LLC | 1 | $19 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $14 |
Products named: VRAYLAR, REXULTI, Qelbree, CAPLYTA.
Industry payments across PA — which companies pay providers there.
